Topical 0.4% Ketorolac and Vitreoretinal Surgery

Topical 0.4% Ketorolac for the Inhibition of Miosis During Vitreoretinal Surgery: a Randomized, Placebo-controlled, Double-masked Study

To determine whether use of topical 0.4% ketorolac has any effect on pupil size during vitreoretinal surgery.

Other outcomes will be to assess postoperative pain and inflammation and visual acuity.

Inclusion Criteria:

• Age of 18, routine elective vitrectomy

Exclusion Criteria:

• history of trauma, uveitis, prior intraocular surgery within 3 months, requirement of mechanical pupil dilation, prior inclusion of other eye